文献速递淋巴瘤

中低收入国家儿童侵袭性B细胞非霍奇金淋巴瘤

Childhood aggressive B-cell non-Hodgkin lymphoma in low-middle-income countries.
PubMed 文献 · Br J Haematol · 2021-12-06

本文综述中低收入国家儿童侵袭性B细胞非霍奇金淋巴瘤的管理现状。高收入国家约90%病例可治愈,而中低收入国家治愈率从不足30%至约70%不等,且90%儿童非霍奇金淋巴瘤发生在中低收入国家。社会经济文化条件差、诊断与实验室设施不足及支持治疗缺乏对依从性、治疗实施和毒性产生负面影响,已开展的国家和国际合作项目初步结果令人鼓舞。

要点

  • 高收入国家儿童侵袭性B细胞淋巴瘤约90%可治愈
  • 中低收入国家治愈率从不足30%至约70%不等
  • 90%儿童非霍奇金淋巴瘤发生在中低收入国家

核心结论

  • 中低收入国家儿童侵袭性B细胞非霍奇金淋巴瘤治愈率从不足30%至约70%不等,远低于高收入国家的约90%。

研究设计与样本

  • 本文为综述,总结中低收入国家儿童侵袭性B细胞非霍奇金淋巴瘤管理迄今获得的结果。

主要发现

  • 高收入国家儿童侵袭性B细胞淋巴瘤约90%病例可治愈。
  • 中低收入国家治愈率从不足30%至约70%不等。
  • 90%儿童非霍奇金淋巴瘤发生在中低收入国家。
  • 低社会经济和文化条件、缺乏最佳诊断程序、实验室设施和充分支持治疗对依从性、治疗实施、毒性和临床结局产生强烈负面影响。
  • 已发表数据稀少,通常来自单一机构,且难以比较。

临床怎么用

  • 已开展国家和国际合作项目,通过促进知识共享和实施适当的当地医疗设施来缩小高收入国家与中低收入国家在儿童癌症管理中的差距,初步结果令人鼓舞。

局限性

  • 已发表数据稀少,通常来自单一机构,且难以比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In high-income countries (HICs) paediatric aggressive B-cell lymphomas are curable in about 90% of cases. Much worse results, with cure rates ranging from less than 30% to about 70%, are achieved in low- and middle-income countries (LMICs), where 90% of paediatric non-Hodgkin lymphomas occur. Low socio-economic and cultural conditions, the lack of optimal diagnostic procedures, laboratory facilities and adequate supportive care exert a strong negative impact on compliance, treatment delivery, toxicity and, consequently, on the clinical outcome. Published data are scarce, generally originating from single institutions, and are difficult to compare. National and international cooperation projects have been undertaken to reduce the unacceptable gap between HICs and LMICs in the management of children with cancer, by promoting the sharing of knowledge and by implementing adequate local healthcare facilities, with initial promising results. In the present review, we will summarize the results so far obtained in the management of paediatric aggressive B-cell NHL in LMICs.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Moleti ML, Testi AM, Foà R, et al. Childhood aggressive B-cell non-Hodgkin lymphoma in low-middle-income countries. Br J Haematol. 2021. PMID: 34866182. doi:10.1111/bjh.17979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。